ANNIE CONWAY: Open Payments
NPI 1477209401 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 59 payments from 8 companies in 2025. Trend: 2023 $1,071 · 2024 $853 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $312 |
| Aimmune Therapeutics, Inc. | 9 | $185 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $182 |
| Janssen Biotech, Inc. | 7 | $140 |
| Regeneron Healthcare Solutions, Inc. | 4 | $82 |
| Intercept Pharmaceuticals, Inc. | 3 | $45 |
| Globus Medical, Inc. | 1 | $28 |
| Ardelyx, Inc. | 1 | $23 |
Products named: ZENPEP, RELISTOR, TREMFYA, LINZESS, RINVOQ, DUPIXENT, CREON, OCALIVA.
Industry payments across AR — which companies pay providers there.
